Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:02 PM
Ignite Modification Date:
2025-12-24 @ 11:02 PM
NCT ID:
NCT00738569
Eligibility Criteria:
Inclusion Criteria:
1. At least 18 years of age
2. HIV-positive by Western blot or viral load
3. Viral load \< 400 copies/ml
4. CD4+ T-lymphocyte count less than 350 cells/mm3 or change in CD4+ T-lymphocyte count \< 100 cells/mm3 for at least one year on stable HAART with viral load \< 400 copies/ml for the same period of time
Exclusion Criteria:
1. CD4+ T-lymphocyte count greater than or equal to 350 cells/mm3 or rise in CD4+ T-lymphocyte count greater than or equal to 100 cells/mm3 within one year of study entry
2. Viral load \> 400 copies/ml
3. Allergy or resistance to raltegravir
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00738569
Study Brief:
Protocol Section:
NCT00738569